Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database
Author | Tobaiqy, Mansour |
Author | MacLure, Katie |
Author | Elkout, Hajer |
Author | Stewart, Derek |
Available date | 2021-11-29T10:38:24Z |
Publication Date | 2021-11-23 |
Publication Name | Vaccines |
Identifier | http://dx.doi.org/10.3390/vaccines9111326 |
Citation | Tobaiqy, M.; MacLure, K.; Elkout, H.; Stewart, D. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines 2021, 9, 1326. https://doi.org/10.3390/vaccines9111326 |
Identifier | 1326 |
Abstract | Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database |
Language | en |
Publisher | MDPI |
Subject | vaccines COVID-19 adverse events adverse drug reaction thrombotic COVID-19 vaccine Pfizer Moderna AstraZenaca |
Type | Article |
Volume Number | 9 |
Files in this item
This item appears in the following Collection(s)
-
COVID-19 Research [838 items ]
-
Pharmacy Research [1320 items ]